Investors looking for stocks that can put up dramatic gains in a short amount of time naturally flock to biotech stocks. Hardly a week goes by without at least one drugmaker stock surging in response to clinical trial results, regulatory decisions, or buyout offers.

Up and down Wall Street, the investment bank analysts have been telling anyone who'll listen to buy these biotech stocks before they soar. The average price target on these stocks suggests some dramatic gains could be up ahead.

Image source: Getty Images.

Continue reading

Source Fool.com